This report studies the global H1N1 Vaccines market status and forecast, categorizes the global H1N1 Vaccines market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
Download FREE Sample of this Report @ https://www.24marketreports.com/report-sample/global-hn-vaccines-2018-580
A vaccine is a biological preparation consisting of an agent that closely resembles a disease-causing microorganism and is made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.The global H1N1 vaccination market is anticipated to boost in the focus period due to the rising cases of swine flu. Additionally, the rising geriatric population increases the risk of respiratory tract diseases, and immune deficient diseases, thus increasing the risk factor for acquiring H1N1 influenza. Moreover, increased research in the field of vaccine technologies and significant government support are driving this market. However, lack of awareness and absence of experienced medical professionals are restraining the growth of H1N1 vaccines market. Furthermore, high capital requirement and stringent regulations are also hindering the growth of the global H1N1 vaccination market.
The Americas led the global H1N1 vaccines market and is expected to reach close to USD 2 billion by 2020. Factors such as the higher incidences of H1N1 infections in the US and the affordability of treatment due to well-structured reimbursement health plans to propel this market’s growth in the region. Furthermore, the increasing use of combination vaccines and the introduction of novel vaccines is anticipated to drive the growth of this market in the Americas.
The global H1N1 Vaccines market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.
The major players covered in this report
- Abbott
- Baxter International
- Sanofi
- GSK
- Pfizer
- Mitsubishi Tanabe Pharma
- Hualan Biological Engineering
- Cipla
- Merck
- Sinovac Biotech
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
- United States
- Europe
- China
- Japan
- Southeast Asia
- India
We can also provide the customized separate regional or country-level reports, for the following regions:
- North America
- United States
- Canada
- Mexico
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Singapore
- Rest of Asia-Pacific
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Russia
- Rest of Europe
- Central & South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- Turkey
- Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
- Intramuscular Vaccines
- Intranasal Vaccines
- Intradermal Vaccines
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
- Influenza
- Meningococcal
- Cervical Cancer
- Pneumococcal
- Hepatitis
- Measles
- Mumps
- Rubella
- Others
The study objectives of this report are:
- To analyze and study the global H1N1 Vaccines sales, value, status (2013-2017) and forecast (2018-2025);
- To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
- Focuses on the key H1N1 Vaccines players, to study the sales, value, market share and development plans in future.
- Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
- To define, describe and forecast the market by type, application and region.
- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
- To identify significant trends and factors driving or inhibiting the market growth.
- To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
- To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
- To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of H1N1 Vaccines are as follows:
- History Year: 2013-2017
- Base Year: 2017
- Estimated Year: 2018
- Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
- H1N1 Vaccines Manufacturers
- H1N1 Vaccines Distributors/Traders/Wholesalers
- H1N1 Vaccines Subcomponent Manufacturers
- Industry Association
- Downstream Vendors
Available Customizations
With the given market data, We Research offers customizations according to the company’s specific needs. The following customization options are available for the report:
- Regional and country-level analysis of the H1N1 Vaccines market, by end-use.
- Detailed analysis and profiles of additional market players.
Table of content
Global H1N1 Vaccines Sales Market Report 2018
1 H1N1 Vaccines Market Overview
1.1 Product Overview and Scope of H1N1 Vaccines
1.2 Classification of H1N1 Vaccines by Product Category
1.2.1 Global H1N1 Vaccines Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global H1N1 Vaccines Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Intramuscular Vaccines
1.2.4 Intranasal Vaccines
1.2.5 Intradermal Vaccines
1.3 Global H1N1 Vaccines Market by Application/End Users
1.3.1 Global H1N1 Vaccines Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.1 Influenza
1.3.2 Meningococcal
1.3.3 Cervical Cancer
1.3.4 Pneumococcal
1.3.5 Hepatitis
1.3.6 Measles
1.3.7 Mumps
1.3.8 Rubella
1.3.9 Others
1.4 Global H1N1 Vaccines Market by Region
1.4.1 Global H1N1 Vaccines Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States H1N1 Vaccines Status and Prospect (2013-2025)
1.4.3 Europe H1N1 Vaccines Status and Prospect (2013-2025)
1.4.4 China H1N1 Vaccines Status and Prospect (2013-2025)
1.4.5 Japan H1N1 Vaccines Status and Prospect (2013-2025)
1.4.6 Southeast Asia H1N1 Vaccines Status and Prospect (2013-2025)
1.4.7 India H1N1 Vaccines Status and Prospect (2013-2025)
CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170
Email: help@24marketreports.com
Follow Us On linkedin :- https://www.linkedin.com/company/24-market-reports